Management of a pediatric patient on the Berlin Heart Excor ventricular assist device with argatroban after heparin-induced thrombocytopenia

ASAIO J. 2008 Sep-Oct;54(5):546-7. doi: 10.1097/MAT.0b013e3181873681.

Abstract

We report a 15-year-old male patient who developed type II heparin-induced thrombocytopenia (HIT) after 6 weeks of heparin administration and placement of a Berlin Heart Excor left ventricular assist device (LVAD).

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Arginine / analogs & derivatives
  • Aspirin / administration & dosage
  • Dipyridamole / administration & dosage
  • Drug Interactions
  • Heart Transplantation
  • Heart-Assist Devices*
  • Heparin / administration & dosage
  • Heparin / adverse effects*
  • Heparin Antagonists / administration & dosage
  • Humans
  • Infusions, Intravenous
  • International Normalized Ratio
  • Length of Stay
  • Male
  • Pipecolic Acids / therapeutic use*
  • Platelet Aggregation Inhibitors / administration & dosage
  • Protamines / administration & dosage
  • Sulfonamides
  • Thrombin / antagonists & inhibitors
  • Thrombin / therapeutic use
  • Thrombocytopenia / chemically induced*
  • Time Factors
  • Treatment Outcome
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Heparin Antagonists
  • Pipecolic Acids
  • Platelet Aggregation Inhibitors
  • Protamines
  • Sulfonamides
  • Warfarin
  • Dipyridamole
  • Heparin
  • Arginine
  • Thrombin
  • argatroban
  • Aspirin